knowledge -WSS

knowledge

author：focus 2025-10-04 12:06:38 Page View：345

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump seeks lengthy delay of classified docs trial, citing upcoming election
Next article： Cancer drug shortages should be causing more outrage

knowledge

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Mass General Brigham physicians react to latest merger step

SuhasGondiofBrighamandWomen'sHospitalhasresearchedandwrittenabouthospitalboardsincreasinglybeingmade

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

1:10PresidentJoeBidenparticipatesinaceremonialarrivalandinspectionofthehonorguardwithBritain'sKingCh

knowledge

explore

knowledge

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation